Distinct Thresholds of Infliximab Trough Level Are Associated with Different Therapeutic Outcomes in Patients with Inflammatory Bowel Disease: A Prospective Observational Study.

about

Distinct Thresholds of Infliximab Trough Level Are Associated with Different Therapeutic Outcomes in Patients with Inflammatory Bowel Disease: A Prospective Observational Study.

Item

http://www.wikidata.org/entity/Q47747881

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Distinct Thresholds of Inflixi ...... ospective Observational Study.

@en

Distinct Thresholds of Inflixi ...... ospective Observational Study.

@nl

type

Item

label

Distinct Thresholds of Inflixi ...... ospective Observational Study.

@en

Distinct Thresholds of Inflixi ...... ospective Observational Study.

@nl

prefLabel

Distinct Thresholds of Inflixi ...... ospective Observational Study.

@en

Distinct Thresholds of Inflixi ...... ospective Observational Study.

@nl

P1476

Distinct Thresholds of Inflixi ...... ospective Observational Study.

@en

P2093

Emilie Deltedesco

http://www.w3.org/2001/XMLSchema#string

Gérard Duru

http://www.w3.org/2001/XMLSchema#string

Jean M Phelip

http://www.w3.org/2001/XMLSchema#string

Laurent Peyrin-Biroulet

http://www.w3.org/2001/XMLSchema#string

Nicolas Williet

http://www.w3.org/2001/XMLSchema#string

P2860

Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial

Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease.

A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease.

Systematic Review and Meta-Analysis: Serum Infliximab Levels During Maintenance Therapy and Outcomes in Inflammatory Bowel Disease

Adalimumab trough serum levels and anti-adalimumab antibodies in the long-term clinical outcome of patients with Crohn's disease.

Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases.

Correlation Between Concentrations of Fecal Calprotectin and Outcomes of Patients With Ulcerative Colitis in a Phase 2 Trial.

Relationship between serum infliximab trough levels and endoscopic activities in patients with Crohn's disease under scheduled maintenance treatment.

P304

2048-2053

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MIB.0000000000001223

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28945636

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases